R&D

Jumpstart takes a look at Artificial Intelligence

Our partner, Jumpstart, takes a look at the application of technologies like Artificial Intelligence to recognise speed signs, work with talking machines and protect our personal and business data. 

Technology continues to accelerate  and innovative companies are buildng new products and...

Is the UK’s tech sector missing out on R&D tax relief?

In the second of the Company Connecting series on R&D Tax credits, our guest author Mark Westwood, a technical analyst at Jumpstart asks the question "Is the UK’s tech sector missing out on R&D tax relief?"

We continue our series on R&D Tax relief with an article from our guest author,Mark Westwood of Jumpstart. He asks the question "Is the UK’s tech sector missing out on R&D tax relief?"

The UK’s technology sector is widely acknowledged as one of the fastest growing areas of the economy, with Prime Minister Theresa May describing it earlier this year as a "great British success story".

Image accompanying the article "Is the UK’s tech sector missing out on R&D tax relief?" The image asks 'How much is the average  R& D tax relief claim  for  Software Development?'

An Idiots Guide to R & D Tax Credits

Company Connecting has partnered with Jumpstart to provide information on the Government R & D Tax Credit Scheme. Over the next few weeks we will be publishing several articles to provide a better understanding of the scheme. We will also be publishing more infographics on tech areas such as...

Benevolent AI: Shaping the Future of Scientific Discovery

Benevolent AI are a London based company who use artificial intelligence to understand and reimagine scientific discovery.

Despite the huge growth of knowledge, scientific discovery has not changed for 50 years.  It’s impossible for humans alone to process all the information potentially available to advance scientific research.  A new scientific paper is published every 30 seconds, there are 10,000 updates to PubMed every day.  Consequently, only a small fraction of globally generated scientific information can form ‘useable’ knowledge.  Specifically, in Pharma innovation has not changed (cost, time & risk – still applying 20th Century methods to 21st Century problems) and is not meeting the needs of patients – patients are unnecessarily waiting for new medicines.

BenevolentAI are applying its proprietary AI technology to change this problem by enabling the analysis of vast quantities of complex scientific information and creating usable knowledge that can be applied.

Logo for Benevolent AI accompanying the article Benevolent AI: Shaping the Future of Scientific Discovery